SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...
News-Medical.Net on MSN2d
Breakthrough peptide inhibitor effective against multiple SARS-CoV-2 variantsSARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.
Cybercriminals from the Medusa ransomware group have launched a wave of attacks, exploiting software vulnerabilities through phishing emails and malicious websites.
The volume of data breaches grew 6% year-on-year (YoY) in 2024, fueled by double-digit increases in ransomware, compromised ...
In a study published in the journal, Cell, Jing Chen, PhD, and colleagues at the Wuhan Institute of Virology, Wuhan, China, ...
The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor ...
BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) ...
Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...
NDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGSIf approved, FILSPARI could become the first and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback